SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities
SEC Accession No. 0001179110-13-000850
Filing Date
2013-01-14
Accepted
2013-01-14 18:40:48
Documents
1
Period of Report
2012-12-31
Filing Date Changed
2013-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 5 - edgar.html 5  
1 FORM 5 - edgar.xml 5 3370
  Complete submission text file 0001179110-13-000850.txt   4745
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Issuer) CIK: 0000884629 (see all company filings)

IRS No.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address ONE CVS DR WOONSOCKET RI 02895
Business Address
BODINE CHRIS W (Reporting) CIK: 0001194405 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-13305 | Film No.: 13528891